Benzene and the hemopoietic stem cell

Chemico-Biological Interactions

Volumn 153-154, Issue , 2005, Pages 217-222

  Morgan, Gareth J ^a   Alvares, Caroline L ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Acute myeloid leukemia; Bone marrow stem cell; CD34; Cytogenetics; Genomic instability

Indexed keywords

BENZENE; CCAAT ENHANCER BINDING PROTEIN ALPHA; DNA; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR RUNX1;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; ATAXIA TELANGIECTASIA; BONE MARROW; CHROMATIN STRUCTURE; CHROMOSOME TRANSLOCATION; CPG ISLAND; CYTOGENETICS; DNA DAMAGE; DNA METHYLATION; DNA REPAIR; DNA STRAND BREAKAGE; ENVIRONMENTAL EXPOSURE; EPIGENETICS; FANCONI ANEMIA; GENE DELETION; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOMIC INSTABILITY; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMOGENESIS; MICROENVIRONMENT; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; OXIDATIVE STRESS; RISK FACTOR;

ACUTE DISEASE; BENZENE; ENVIRONMENTAL EXPOSURE; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID;

EID: 20444421895     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2005.03.025     Document Type: Article

References (35)

1. A. Jemal, A. Thomas, T. Murray, and M. Thun Cancer statistics CA Cancer J. Clin. 52 2002 23 47
2. J.M. Bennett, D. Catovsky, M.T. Daniel, G. Flandrin, D.A. Galton, H.R. Gralnick, and C. Sultan Proposed revised criteria for the classification of AML: a report of the French-American-British Co-operative Group Ann. Intern. Med. 103 1985 620 625
3. J.M. Bennett, D. Catovsky, M.T. Daniel, G. Flandrin, D.A. Galton, H.R. Gralnick, and C. Sultan Criteria for the diagnosis of acute leukaemia of megakaryocytic lineage (M7): a report of the French-American-British Co-operative Group Ann. Intern. Med. 103 1985 460 462
4. D. Bonnet, and J.E. Dick Human acute myeloid leukaemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat. Med. 3 1997 730 737
5. U. Duhrsen, and D.K. Hassfeld Stromal abnormalities in neoplastic bone marrow diseases Ann. Hematol. 73 1996 53 70
6. G.F. Kalf Recent advances in the metabolism and toxicity of benzene Crit. Rev. Toxicol. 18 1987 141 159
7. M.P. Handle DNA repair factors and telomere-chromosome integrity in mammalian cells Cytogenet. Genome Res. 104 2004 116 122
8. G.M. Wahl, S.P. Linke, T.G. Paulson, and L.C. Huang Maintaining genetic stability through TP53 mediated checkpoint control Cancer Surv. 29 1997 183 219
9. T. Haferlach, S. Schnittger, W. Kern, W. Hiddemann, and C. Schoch Genetic classification of acute myeloid leukaemia Ann. Hematol. 83 2004 S97 S100
10. K. Mrozek, N.A. Heerema, and C.D. Bloomfield Cytogenetics in acute leukaemia Blood Rev. 18 2004 115 136
11. L.F. Peterson, and D.E. Zhang The 8;21 transloaction in leukaemogenesis Oncogene 23 2004 4255 4262
12. E. Puccetti, and M. Ruthardt Acute promyelocytic leukaemia: PML/RARalpha and the leukaemic stem cell Leukaemia 18 2004 1169 1175
13. J. Delaunay, N. Vey, T. Leblanc, P. Fenaux, F. Rigal-Huguet, F. Witz, T. Lamy, A. Auvrignon, D. Blaise, A. Pigneux, F. Mugneret, C. Bastard, N. Dastugue, J. Van den Akker, D. Fiere, J. Reiffers, S. Castaigne, G. Leverger, J.L. Harousseau, and H. Dombret Prognosis of inv(16)/t(16;16) acute myeloid leukaemia (AML): a survey of cases from the French AML Intergroup Blood 102 2003 462 469
14. D. Rund, and D. Ben-Yehuda Therapy-related leukaemia and myelodysplasia: evolving concepts of pathogenesis and treatment Hematology 9 2004 179 187
15. M.K. Andersen, D.H. Christiansen, B.A. Jensen, P. Ernst, G. Hauge, and J. Pedersen-Bjergaard Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992 Br. J. Haematol. 114 2001 539 543
16. J. Pedersen-Bjergaard Radiation and chemotherapy induced myelodysplasia and acute myeloid leukaemia: a review Leuk. Res. 16 1992 61 65
17. N. Asou The role of a Runt domain transcription factor AML1/RUNX1 in leukaemogenesis and its clinical implications Crit. Rev. Oncol. Hematol. 45 2003 129 150
18. M. Esteller Profiling aberrant DNA methylation in hematologic neoplasia: a view from the tip of the iceberg Clin. Immunol. 109 2003 80 88
19. S. Frohling, R.F. Schlenk, I. Stolze, J. Bihlmayr, A. Benner, S. Kreitmeier, K. Tobis, H. Dohner, and K. Dohner CEBPA mutations in younger adults with acute myeloid leukaemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations J. Clin. Oncol. 22 2004 624 633
20. D.G. Gilliland, and J.D. Griffin The roles of FLT3 in hematopoiesis and leukaemia Blood 100 2002 1532 1542
21. P. Ganly, L.C. Walker, and C.M. Morris Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to AML Leuk. Lymphoma 45 2004 1 10
22. I.P. Touw, and F. Dong Severe congenital neutropenia terminating in AML: disease progression associated with mutations in the GCSF receptor gene Leuk. Res. 20 1996 629 631
23. J.W. Taub, and Y. Ge Down syndrome, drug metabolism and chromosome 21 Ped. Blood Cancer 44 2005 33 39
24. P.B. Langmuir, R. Aplenc, and B.J. Lange Acute myeloid leukaemia in children Best Pract. Res. Clin. Hematol. 14 2001 77 93
25. S. Bhatia, and J.P. Neglia Epidemiology of childhood acute myelogenous leukaemia J. Paediatr. Hematol. Oncol. 17 1995 94 100
26. G.K. Dasika, S.C. Lin, S. Zhao, P. Sung, A. Tomkinson, and E.Y. Lee DNA damage induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis Oncogene 18 1999 7883 7899
27. J. Whysner, M.V. Reddy, P.M. Ross, M. Mohan, and E.A. Lax Genotoxicity of benzene and its metabolites Mutat. Res. 566 2004 99 130
28. G.J. Morgan, and M.T. Smith Metabolic enzyme polymorphisms and susceptibility to acute leukaemia in adults Am. J. Pharmacogenomics 2 2002 79 92
29. D. Sinnett, M. Krajinovic, and D. Labuda Genetic susceptibility to childhood acute lymphoblastic leukaemia Leuk. Lymphoma 38 2000 447 462
30. D.J. Paustenbach, R.D. Bass, and P. Price Benzene toxicity and risk assessment 1972-1992: implications for future regulations Environ. Health Perspect. 101 1993 177 200
31. U. Rangan, and R. Snyder Scientific update on benzene Ann. N. Y. Acad. Sci. 837 1997 105 113
32. D. Ross, D. Siegel, D.G. Schattenberg, X.M. Sun, and J.L. Moran Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: identification of target cells and a potential role for modulation of apoptosis in benzene toxicity Environ. Health Perspect. 104 1996 1177 1182
33. H. Nakakuma, and T. Kawaguchi Pathogenesis of selective expansion of PNH clones Int. J. Hematol. 77 2003 121 124
34. J. Barrett, Y. Saunthararajah, and J. Molldrem Myelodysplastic syndrome and aplastic anaemia: distinct entities or diseases linked by a common pathophysiology? Semin. Hematol. 37 2000 15 29
35. Y. Hirabayashi, B.I. Yoon, G.X. Li, J. Kanno, and T. Inoue Mechanism of benzene-induced hematotoxicity and leukemogenicity: current review with implication of microarray analyses Toxicol. Pathol. 32 2004 12 16